# Chuck Farkas

> Chuck Farkas is a private equity investor at Altamont Capital Partners backing Genetics. See 1 investments, check sizes, portfolio and contact details…

- Type: Angel Investor
- Fund: [Altamont Capital Partners](https://shizune.co/investors/profile/altamont-capital-partners)
- Location: Boston, United States
- Total investments: 1
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/chuck-farkas-01a5131b

Chuck Farkas is a private equity investor at Altamont Capital Partners in Boston focused on Genetics and Life Science. Charles Farkas became an Advisory Partner at Bain & Company in July, 2015. Prior to that he was a Senior Partner in Bain & Company’s Boston office. He joined the firm in 1979 and was elected to the partnership in 1985. Mr. Farkas advises chief executives and senior managers in a wide variety of industries on issues critical to long-termsuccess. He has served as the global leader of Bain & Company’s Financial Services practice, the North American head of Bain’s Healthcare practice and as the Managing Director of Bain Canada.He has worked globally with companies in a wide range of industries including healthcare providers and suppliers, banking, insurance, brokerage, credit cards, consumer goods, retailing and industrial products.With over 36 years of experience, Mr. Farkas is highly sought out by clients for his experience with issues of growth, strategy, leadership and change. He is the author of the best-selling book Maximum Leadership (1996) and numerous articles published in the Harvard Business Review, Fortune, In Vivo and other publications. In 2008 Consulting Magazine named Mr. Farkas one of the Top 25 Global Consultants.

## Contacts

5 contacts available for Chuck Farkas: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/chuck-farkas?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Genetics | 1 | 100% |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Courtagen Life Sciences | Courtagen Life Sciences is a biotech company that provides proteomic and genomic products and services to the life sciences industry. The company delivers tools that enable researchers and clinicians to make better decisions regarding drug development and patient care. It was founded in 1999 and headquartered in Woburn, Massachusetts. | $20M | Private Equity | Jul 01, 2015 |  |

1 of 1 investments shown.

## Co-investors
- [First Analysis](https://shizune.co/investors/profile/first-analysis) — VC Fund, 1 deal together
- [Harbor Light Capital Partners](https://shizune.co/investors/profile/harbor-light-capital-partners) — VC Fund, 1 deal together

## About Altamont Capital Partners

VC Fund · Palo Alto, United States

Altamont Capital Partners is a private investment firm based in the San Francisco Bay Area with more than $2.5 billion of assets under management.The firm is focused on investing in middle-market businesses where it can partner with leading management teams to help its portfolio companies reach their full potential. The firm’s principals havesignificant experience building business success stories across a range of industries, including consumer, restaurants and multi-unit, financial services, healthcare, industrials, and business services.The Palo Alto, California-headquartered company was founded in 2011 by Jesse Rogers, Keoni Schwartz, and Randall Eason.

5 contacts available at Altamont Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Chuck Farkas | Operating Partner | https://shizune.co/investors/profile/chuck-farkas |
| Dave Odenath | Operating Partner | https://shizune.co/investors/profile/dave-odenath |
| Jesse Rogers | Co-Founder and Managing Director | https://shizune.co/investors/profile/jesse-rogers-2 |
| K.C. Moylan | Operating Partner | https://shizune.co/investors/profile/k-c-moylan |
| Ailyn Fun | Director and Head of Investor Relations | https://shizune.co/investors/profile/ailyn-fun-4d93 |

## Similar investors

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

## FAQ

### What does Chuck Farkas invest in?

Chuck Farkas invests primarily in Genetics, Life Science and Biotechnology startups, most often at Private Equity stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Chuck Farkas?

Public channels for Chuck Farkas include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co